Nautilus Biotechnolgy Inc.
NAUT | NASDAQ
$1
+$0.05 (+4.74%)
Sep 22, 2026, 1:55 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -4.15 | -3 | -5.86 | -3.91 | -8.63 | -23.09 |
PEG Ratio | 0.26 | -0.31 | -0.54 | 0.17 | -0.31 | 0.33 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.57 | 1.01 | 1.41 | 0.71 | 1.20 | -12.07 |
P/FCF Ratio | -4.74 | -3.44 | -6.90 | -4.66 | -10.54 | -24.05 |
P/OCF Ratio | -4.86 | -3.56 | -7.22 | -4.90 | -11.15 | -25.64 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.19 | 0.15 | 0.13 | 0.10 | 0.08 | -0.16 |
Quick Ratio | 13.33 | 17.40 | 19.39 | 27.57 | 60.09 | 25.73 |
Current Ratio | 13.33 | 17.40 | 19.39 | 27.57 | 60.09 | 25.73 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -10.94 | n/a | n/a |
Return on Equity | -37.59% | -33.91% | -24% | -18.39% | -13.84% | 52.55% |
Return on Assets | -30.87% | -29.16% | -20.84% | -16.55% | -12.63% | -18.37% |
Return on Invested Capital | -35.74% | -34.06% | -25.39% | -18.43% | -12.83% | -18.86% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove NAUT